Novacyt S.A.: Update on CE Mark Approved coronavirus test
14 Février 2020 - 04:39PM
Business Wire
Regulatory News:
Novacyt (EURONEXT GROWTH: ALNOV; AIM: NCYT), an international
specialist in clinical diagnostics, is pleased to announce that,
further to its announcement on 7 February 2020, its subsidiary,
Primerdesign Limited, is on schedule to launch a CE-Mark approved
nCoV test in the week commencing 17 February 2020. The Primerdesign
website has commenced taking orders for the CE-marked test ahead of
the planned launch next week.
- End –
About Novacyt Group
The Novacyt Group is an international diagnostics business
generating an increasing portfolio of in vitro and molecular
diagnostic tests. Its core strengths lie in diagnostics product
development, commercialisation, contract design and manufacturing.
The Company's lead business units comprise of Primerdesign and
Lab21 Products, supplying an extensive range of high-quality assays
and reagents worldwide. The Group directly serves microbiology,
haematology and serology markets as do its global partners, which
include major corporates.
For more information please refer to the website:
www.novacyt.com
About 2019-nCoV
Researchers at the Chinese Centre for Disease Control and
Prevention and their collaborators have sequenced the 2019 novel
coronavirus (2019-nCoV) pathogen from patient samples and have
found it to be genetically distinct from the severe acute
respiratory syndrome (SARS) virus that caused an epidemic in 2002
and 2003, as well as from the Middle East respiratory syndrome
(MERS) virus that was detected in 2012.
View source
version on businesswire.com: https://www.businesswire.com/news/home/20200214005356/en/
Novacyt SA Graham Mullis, Chief Executive Officer Anthony
Dyer, Chief Financial Officer +44 (0)1276 600081
SP Angel Corporate Finance LLP (Nominated Adviser and
Broker) Matthew Johnson / Charlie Bouverat (Corporate Finance)
Vadim Alexandre / Rob Rees (Corporate Broking) +44 (0)20 3470
0470
FTI Consulting (International) Victoria Foster
Mitchell/Mary Whittow +44 (0)20 3727 1000
victoria.fostermitchell@fticonsulting.com /
mary.whittow@fticonsulting.com
FTI Consulting (France) Arnaud de Cheffontaines / Astrid
Villette +33 (0)147 03 69 47 / +33 (0)147 03 69 51
arnaud.decheffontaines@fticonsulting.com /
astrid.villette@fticonsulting.com
Novacyt (EU:ALNOV)
Graphique Historique de l'Action
De Fév 2024 à Mar 2024
Novacyt (EU:ALNOV)
Graphique Historique de l'Action
De Mar 2023 à Mar 2024